Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-001715
Filing Date
2025-01-17
Accepted
2025-01-17 17:54:57
Documents
1
Period of Report
2025-01-15

Document Format Files

Seq Description Document Type Size
1 form4-01172025_100154.html 4  
1 form4-01172025_100154.xml 4 3835
  Complete submission text file 0001415889-25-001715.txt   5362
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Issuer) CIK: 0001496323 (see all company filings)

EIN.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AEGLEA BIOTHERAPEUTICS, INC. 805 LAS CIMAS PARKWAY, SUITE 100 AUSTIN TX 78746
Business Address
Weber Steven (Reporting) CIK: 0001844594 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39045 | Film No.: 25539817